Drug intelligence / Profile preview

Sj-B6 mRNA vaccine

Development stage
Preclinical
Lead developer
PAI Life Sciences
Modality
Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

Sj-B6 mRNA vaccine is a veterinary self-replicating RNA (repRNA) vaccine candidate designed to prevent Asiatic schistosomiasis, a neglected tropical disease caused by the parasite *Schistosoma japonicum*. The vaccine targets the secretory serine protease inhibitor (serpin) Sj-B6, which is expressed during the intra-mammalian life cycle stages of the parasite, particularly in the eggs, and is believed to play a role in disease transmission and host immune modulation. The vaccine utilizes HDT Bio's proprietary LION™ (Lipid InOrganic Nanoparticle) carrier platform to adsorb and stabilize the repRNA, allowing it to persist longer in vivo. It is being developed as a transmission-blocking veterinary vaccine, particularly for bovines, to interrupt the parasite's life cycle and reduce transmission to humans.

Other names
Sj-B6 repRNA/LION vaccineSj-B6 self-replicating RNA vaccineSj-B-6 self-replicating RNA vaccineSj-B 6 self-replicating RNA vaccine

Beyond the preview

Go deeper on Sj-B6 mRNA vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sj-B6 mRNA vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call